Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response
about
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy of a 12-Week Simeprev ...... n-Treatment Virologic Response
@ast
Efficacy of a 12-Week Simeprev ...... n-Treatment Virologic Response
@en
type
label
Efficacy of a 12-Week Simeprev ...... n-Treatment Virologic Response
@ast
Efficacy of a 12-Week Simeprev ...... n-Treatment Virologic Response
@en
prefLabel
Efficacy of a 12-Week Simeprev ...... n-Treatment Virologic Response
@ast
Efficacy of a 12-Week Simeprev ...... n-Treatment Virologic Response
@en
P2093
P2860
P1433
P1476
Efficacy of a 12-Week Simeprev ...... n-Treatment Virologic Response
@en
P2093
Antonio Craxí
Catherine Nalpas
Ceyhun Bicer
Christoph Sarrazin
Christophe Moreno
Faisal Sanai
Gino Van Dooren
Graham R Foster
Isabelle Lonjon-Domanec
Maria Buti
P2860
P304
P356
10.1371/JOURNAL.PONE.0168713
P407
P577
2017-01-05T00:00:00Z